222 related articles for article (PubMed ID: 24078696)
21. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
22. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
[TBL] [Abstract][Full Text] [Related]
24. Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease.
Haywood ME; Rogers NJ; Rose SJ; Boyle J; McDermott A; Rankin JM; Thiruudaian V; Lewis MR; Fossati-Jimack L; Izui S; Walport MJ; Morley BJ
J Immunol; 2004 Oct; 173(7):4277-85. PubMed ID: 15383556
[TBL] [Abstract][Full Text] [Related]
25. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis.
Coquet JM; Chakravarti S; Smyth MJ; Godfrey DI
J Immunol; 2008 Jun; 180(11):7097-101. PubMed ID: 18490706
[TBL] [Abstract][Full Text] [Related]
26. Orphan Nuclear Receptor NR2F6 Suppresses T Follicular Helper Cell Accumulation through Regulation of IL-21.
Olson WJ; Jakic B; Labi V; Schoeler K; Kind M; Klepsch V; Baier G; Hermann-Kleiter N
Cell Rep; 2019 Sep; 28(11):2878-2891.e5. PubMed ID: 31509749
[TBL] [Abstract][Full Text] [Related]
27. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
[TBL] [Abstract][Full Text] [Related]
28. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.
Herber D; Brown TP; Liang S; Young DA; Collins M; Dunussi-Joannopoulos K
J Immunol; 2007 Mar; 178(6):3822-30. PubMed ID: 17339481
[TBL] [Abstract][Full Text] [Related]
29. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1).
Sugiyama N; Nakashima H; Yoshimura T; Sadanaga A; Shimizu S; Masutani K; Igawa T; Akahoshi M; Miyake K; Takeda A; Yoshimura A; Hamano S; Yoshida H
Ann Rheum Dis; 2008 Oct; 67(10):1461-7. PubMed ID: 18094002
[TBL] [Abstract][Full Text] [Related]
30. Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.
Ansén S; Butler MO; Berezovskaya A; Murray AP; Stevenson K; Nadler LM; Hirano N
Clin Cancer Res; 2008 Oct; 14(19):6125-36. PubMed ID: 18829491
[TBL] [Abstract][Full Text] [Related]
31. Monocytosis in BXSB mice is due to epistasis between Yaa and the telomeric region of chromosome 1 but does not drive the disease process.
Rogers NJ; Gabriel L; Nunes CT; Rose SJ; Thiruudaian V; Boyle J; Morley BJ
Genes Immun; 2007 Dec; 8(8):619-27. PubMed ID: 17728791
[TBL] [Abstract][Full Text] [Related]
32. The Yaa gene-mediated acceleration of murine lupus: Yaa- T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo.
Fossati L; Sobel ES; Iwamoto M; Cohen PL; Eisenberg RA; Izui S
Eur J Immunol; 1995 Dec; 25(12):3412-7. PubMed ID: 8566031
[TBL] [Abstract][Full Text] [Related]
33. Circulating TFH subset distribution is strongly affected in lupus patients with an active disease.
Le Coz C; Joublin A; Pasquali JL; Korganow AS; Dumortier H; Monneaux F
PLoS One; 2013; 8(9):e75319. PubMed ID: 24069401
[TBL] [Abstract][Full Text] [Related]
34. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice.
Merino R; Fossati L; Lacour M; Lemoine R; Higaki M; Izui S
Eur J Immunol; 1992 Feb; 22(2):295-9. PubMed ID: 1537372
[TBL] [Abstract][Full Text] [Related]
35. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells.
Amano H; Amano E; Moll T; Marinkovic D; Ibnou-Zekri N; Martinez-Soría E; Semac I; Wirth T; Nitschke L; Izui S
J Immunol; 2003 Mar; 170(5):2293-301. PubMed ID: 12594250
[TBL] [Abstract][Full Text] [Related]
36. New developments implicating IL-21 in autoimmune disease.
Ren HM; Lukacher AE; Rahman ZSM; Olsen NJ
J Autoimmun; 2021 Aug; 122():102689. PubMed ID: 34224936
[TBL] [Abstract][Full Text] [Related]
37. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients.
Qin WZ; Chen LL; Pan HF; Leng RX; Zhai ZM; Wang C; Li RJ; Wang S; Wang HP; Ye DQ
Clin Exp Med; 2011 Dec; 11(4):245-50. PubMed ID: 21487830
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
Cabrera CM; Urra JM; Carreño A; Zamorano J
Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
[TBL] [Abstract][Full Text] [Related]
39. The role of the Yaa gene in lupus syndrome.
Izui S; Merino R; Fossati L; Iwamoto M
Int Rev Immunol; 1994; 11(3):211-30. PubMed ID: 7930846
[TBL] [Abstract][Full Text] [Related]
40. Phenotype conversion from rheumatoid arthritis to systemic lupus erythematosus by introduction of Yaa mutation into FcγRIIB-deficient C57BL/6 mice.
Kawano S; Lin Q; Amano H; Kaneko T; Nishikawa K; Tsurui H; Tada N; Nishimura H; Takai T; Shirai T; Takasaki Y; Hirose S
Eur J Immunol; 2013 Mar; 43(3):770-8. PubMed ID: 23280344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
